Repair of and checkpoint response to topoisomerase I-mediated DNA damage

被引：243

作者：

Pommier, Y ^{[1
]}

Redon, C ^{[1
]}

Rao, VA ^{[1
]}

Seiler, JA ^{[1
]}

Sordet, O ^{[1
]}

Takemura, H ^{[1
]}

Antony, S ^{[1
]}

Meng, LH ^{[1
]}

Liao, ZY ^{[1
]}

Kohlhagen, G ^{[1
]}

Zhang, HL ^{[1
]}

Kohn, KW ^{[1
]}

机构：

[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | 2003年 / 532卷 / 1-2期

关键词：

topoisomerase; homologous recombination; camptothecin; Tdp1; Mre11; ATM; ATR; BRCA1; BRCA2; RAD52; RAD51; RPA; DNA-PK; cell cycle checkpoints;

D O I：

10.1016/j.mrfmmm.2003.08.016

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Topoisomerase I (Top1) catalyzes two transesterification reactions: single-strand DNA cleavage and religation that are normally coupled for the relaxation of DNA supercoiling in transcribing and replicating chromatin. A variety of endogenous DNA modifications, potent anticancer drugs and carcinogens uncouple these two reactions, resulting in the accumulation of Top I cleavage complexes. Top I cleavage complexes damage DNA and kill cells by generating replication-mediated DNA double-strand breaks (DSBs) and by stalling transcription complexes. The repair of Top1-mediated DNA lesions involves integrated pathways that are conserved from yeasts to humans. Top1-mediated DNA damage and cell cycle checkpoint responses can be studied biochemically and genetically in yeast and human cells with known genetic defects. Defects in these repair/checkpoint pathways, which promote tumor development, explain, at least in part, the selectivity of camptothecins and other Top I inhibitors for cancer cells. (C) 2003 Elsevier B.V. All rights reserved.

引用

页码：173 / 203

页数：31

共 50 条

[21] DNA topoisomerase I-mediated formation of structurally modified DNA duplexes. Effects of metal ions and topoisomerase inhibitors
Wang, XY
Henningfeld, KA
Hecht, SM
BIOCHEMISTRY, 1998, 37 (08) : 2691 - 2700
[22] Topoisomerase I-mediated cleavage at ribonucleotides generates DNA double-strand breaks
Huang, Shar-yin N.
Williams, Jessica S.
Arana, Mercedes E.
Kunkel, Thomas A.
Pommier, Yves
EMBO JOURNAL, 2017, 36 (03): : 361 - 373
[23] ENHANCEMENT OF TOPOISOMERASE I-MEDIATED UNWINDING OF SUPERCOILED DNA BY THE RADIOPROTECTOR WR-33278
HOLWITT, EA
KODA, E
SWENBERG, CE
RADIATION RESEARCH, 1990, 124 (01) : 107 - 109
[24] INDUCTION OF TOPOISOMERASE I-MEDIATED DNA CLEAVAGE BY A NEW INDOLOCARBAZOLE, ED-110
YOSHINARI, T
YAMADA, A
UEMURA, D
NOMURA, K
ARAKAWA, H
KOJIRI, K
YOSHIDA, E
SUDA, H
OKURA, A
CANCER RESEARCH, 1993, 53 (03) : 490 - 494
[25] Human DNA topoisomerase I-mediated cleavage and recombination of duck hepatitis B virus DNA in vitro
Pourquier, P
Jensen, AD
Gong, SS
Pommier, Y
Rogler, CE
NUCLEIC ACIDS RESEARCH, 1999, 27 (08) : 1919 - 1925
[26] EFFECT OF CPT ON THE DNA CLEAVAGE RELIGATION REACTION MEDIATED BY CALF THYMUS TOPOISOMERASE-I - EVIDENCE OF AN INHIBITION OF DNA RELIGATION - INHIBITION OF TOPOISOMERASE I-MEDIATED DNA RELIGATION BY CPT
CARBONI, MC
CODERONI, S
MOLECULAR BIOLOGY REPORTS, 1995, 20 (03) : 129 - 133
[27] Role of SUMOylating enzymes in repair of Topoisomerase II mediated DNA damage
Ramesh, Bhargavi
Sun, Yilun
Nitiss, John L.
Anand, Jay
Nitiss, Karin C.
CANCER RESEARCH, 2019, 79 (13)
[28] Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells
Shih, SJ
Erbele, T
Chen, AY
CANCER RESEARCH, 2005, 65 (20) : 9194 - 9199
[29] Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates
Arimondo, PB
Angenault, S
Halby, L
Boutorine, A
Schmidt, F
Monneret, C
Garestier, T
Sun, JS
Bailly, C
Hélène, C
NUCLEIC ACIDS RESEARCH, 2003, 31 (14) : 4031 - 4040
[30] The roles of Claspin and DNA repair proteins in DNA damage checkpoint response
Praetorius-Ibba, Mette
Wang, Qi-En
Wani, Gulzar
El-Mahdy, Mohamed A.
Zhu, Qianzheng
Wani, Altaf A.
CANCER RESEARCH, 2006, 66 (08)

← 1 2 3 4 5 →